Molecular actions of smoking cessation drugs at 4 2 nicotinic receptors defined in crystal structures of a homologous binding protein
about
Insights into the structural determinants required for high-affinity binding of chiral cyclopropane-containing ligands to α4β2-nicotinic acetylcholine receptors: an integrated approach to behaviorally active nicotinic ligands.Assembly of a π–π stack of ligands in the binding site of an acetylcholine-binding proteinCrystal structure of human glycine receptor-α3 bound to antagonist strychnineNicotinic ACh receptors as therapeutic targets in CNS disordersFunctional probes of drug-receptor interactions implicated by structural studies: Cys-loop receptors provide a fertile testing groundEscherichia coli Protein Expression System for Acetylcholine Binding Proteins (AChBPs)Real time ligand-induced motion mappings of AChBP and nAChR using X-ray single molecule trackingSelective ligand behaviors provide new insights into agonist activation of nicotinic acetylcholine receptors.Efficient expression of acetylcholine-binding protein from Aplysia californica in Bac-to-Bac systemRecent developments in novel antidepressants targeting α4β2-nicotinic acetylcholine receptors.The binding characteristics and orientation of a novel radioligand with distinct properties at 5-HT3A and 5-HT3AB receptorsConformational changes in acetylcholine binding protein investigated by temperature accelerated molecular dynamics.Molecular determinants of subtype-selective efficacies of cytisine and the novel compound NS3861 at heteromeric nicotinic acetylcholine receptors.Cholinergic receptors: functional role of nicotinic ACh receptors in brain circuits and disease.An unusual pattern of ligand-receptor interactions for the α7 nicotinic acetylcholine receptor, with implications for the binding of varenicline.Identifying key amino acid residues that affect α-conotoxin AuIB inhibition of α3β4 nicotinic acetylcholine receptors.Insights into the binding of GABA to the insect RDL receptor from atomistic simulations: a comparison of models.Alpha7 neuronal nicotinic receptors as a drug target in schizophrenia.Physical and virtual screening methods for marine toxins and drug discovery targeting nicotinic acetylcholine receptors.Structural Studies of Nicotinic Acetylcholine Receptors: Using Acetylcholine-Binding Protein as a Structural Surrogate.The development of novel polypharmacological agents targeting the multiple binding sites of nicotinic acetylcholine receptors.Varenicline Interactions at the 5-HT3 Receptor Ligand Binding Site are Revealed by 5-HTBPNon-equivalent ligand selectivity of agonist sites in (α4β2)2α4 nicotinic acetylcholine receptors: a key determinant of agonist efficacy.Investigating the hydrogen-bond acceptor site of the nicotinic pharmacophore model: a computational and experimental study using epibatidine-related molecular probes.An allosteric binding site of the α7 nicotinic acetylcholine receptor revealed in a humanized acetylcholine binding protein.Varenicline and cytisine: two nicotinic acetylcholine receptor ligands reduce ethanol intake in University of Chile bibulous rats.
P2860
Q27671769-4E025622-C0A8-4177-A520-8ECE8D45F1CFQ27678245-5E018986-513F-4FA3-84A8-A9F7DED72631Q27702217-2EC42582-D63B-4850-80BE-632C6187CE2EQ28111941-7AD5CA64-A38A-481E-BBED-407B41304BB5Q28307979-B4B59D86-438D-42F2-B0DB-2060DF8EE006Q28550270-45FA59E1-E207-4E54-B631-AF5D4A05382BQ30587060-828057E4-DF8C-451C-AEB3-44AE16A2BCD0Q33662351-D2991930-154D-4280-AAFD-1A1A3C890A01Q34022402-98535843-2786-4B94-BCA9-F0D78FEFD196Q34394190-D6BED1C9-0D6E-48AD-9E82-08DEA053D476Q34451614-5AAE592A-8A12-4D25-83B2-1CEEF5FF9BE8Q35097431-CE830384-C689-4C58-AA14-5FDF17B13D7AQ36562041-1093DBA7-EF73-4448-B575-3714F9AB927CQ36788258-DB6922D9-CDD3-4F04-A64F-8AE3D4EC93CFQ37027040-BDD02799-5938-449C-B5DA-A2D31BBBF8FAQ37348886-F07A41B6-5AA4-4031-96C8-E592E67D2287Q37589537-0C4AD037-A4D8-42A8-AFB0-C093BF933244Q38066550-2E924E61-57FF-4EA6-AD65-F7B3B57D5723Q38126962-757E6237-9921-4A9D-8F0B-64D983F81DCDQ38634293-DADB492E-A603-492A-9CF3-B4A9A8D76784Q38934855-EE60D5FD-0458-4A9F-99A8-1E40E959F501Q41484397-4405BB95-7F75-4DD1-8A39-2ABC7A699203Q41848168-76EFBE57-98BE-49DD-8520-D5D242B19E2AQ44895743-8D98FAFE-3D32-4C7F-9B6C-CE70FD6D64DAQ47296588-D0F17DCC-4D69-4D52-8E41-17DF221AB872Q50877680-5BB5632A-C083-4D9C-A59D-35CFC6893E66
P2860
Molecular actions of smoking cessation drugs at 4 2 nicotinic receptors defined in crystal structures of a homologous binding protein
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Molecular actions of smoking c ...... f a homologous binding protein
@ast
Molecular actions of smoking c ...... f a homologous binding protein
@en
Molecular actions of smoking c ...... f a homologous binding protein
@nl
type
label
Molecular actions of smoking c ...... f a homologous binding protein
@ast
Molecular actions of smoking c ...... f a homologous binding protein
@en
Molecular actions of smoking c ...... f a homologous binding protein
@nl
prefLabel
Molecular actions of smoking c ...... f a homologous binding protein
@ast
Molecular actions of smoking c ...... f a homologous binding protein
@en
Molecular actions of smoking c ...... f a homologous binding protein
@nl
P2093
P2860
P3181
P356
P1476
Molecular actions of smoking c ...... f a homologous binding protein
@en
P2093
August B Smit
Bert Billen
Chris Ulens
Daniel Bertrand
Jerrel L Yakel
Marijke Brams
Radovan Spurny
René van Elk
Soledad Valera-Kummer
P2860
P304
P3181
P356
10.1073/PNAS.1116397109
P407
P50
P577
2012-06-05T00:00:00Z